RecruitingNCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Sponsor
Duke University
Enrollment
20,000 participants
Start Date
Jul 1, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
Continuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis for future CARRA studies. In particular, this observational registry will be used to answer pressing questions about therapeutics used to treat pediatric rheumatic diseases, including safety questions.
Eligibility
Max Age: 21 Years
Inclusion Criteria3
- Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19 years for all other rheumatic diseases (see appendix A).
- Subject (and/or parent/legal guardian when required) is able to provide written informed consent and willing to comply with study procedures.
- Subject and/or parent/legal guardian is willing to be contacted in the future by study staff.
Exclusion Criteria1
- \. Greater than 21 years of age at the time of enrollment.
Locations(82)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02418442